BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M. Considerations for Heart Failure Care During the COVID-19 Pandemic. JACC Heart Fail 2020;8:681-91. [PMID: 32493638 DOI: 10.1016/j.jchf.2020.05.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G; Critical COVID-19 France Investigators. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021;114:415-25. [PMID: 34099379 DOI: 10.1016/j.acvd.2021.04.003] [Reference Citation Analysis]
2 Hammond MM, Everitt IK, Khan SS. New strategies and therapies for the prevention of heart failure in high-risk patients. Clin Cardiol 2022;45 Suppl 1:S13-25. [PMID: 35789013 DOI: 10.1002/clc.23839] [Reference Citation Analysis]
3 Zhao M, Qin D, Cataldo G, Sharma K, Dandwate N, Orencole MP, Newton-Cheh C, Kevin Heist E, Hucker WJ, Ibrahim N, Singh JP, Das S. Virtual multidisciplinary care for heart failure patients with cardiac resynchronization therapy devices during the Coronavirus Disease 2019 pandemic. Int J Cardiol Heart Vasc 2021;34:100811. [PMID: 34095452 DOI: 10.1016/j.ijcha.2021.100811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, Signorovitch J, Thune JJ, Vardeny O, Solomon SD. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail 2021;9:65-73. [PMID: 33384064 DOI: 10.1016/j.jchf.2020.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
5 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. WJC 2021;13:299-309. [DOI: 10.4330/wjc.v13.i8.299] [Reference Citation Analysis]
6 Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, Contreras J, Mitter SS, LaRocca G, Tlachi P, Brunjes D, Glicksberg BS, Levin MA, Nadkarni G, Fayad Z, Fuster V, Mancini D, Lala A. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol 2020;76:2334-48. [PMID: 33129663 DOI: 10.1016/j.jacc.2020.09.549] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
7 Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic. Cardiovasc Drugs Ther 2021. [PMID: 34328581 DOI: 10.1007/s10557-021-07217-8] [Reference Citation Analysis]
8 Berthelot E, Flécher E, Roubille F, Damy T, Lamblin N; GICC. [Impact de la pandémie de COVID-19 sur la charge des patients atteints d'insuffisance cardiaque chronique en France]. Ann Cardiol Angeiol (Paris) 2021;70:191-5. [PMID: 34517972 DOI: 10.1016/j.ancard.2021.07.002] [Reference Citation Analysis]
9 Mitter SS, Alvarez-Garcia J, Miller MA, Moss N, Lala A. Insights From HeartLogic Multisensor Monitoring During the COVID-19 Pandemic in New York City. JACC Heart Fail 2020;8:1053-5. [PMID: 33272384 DOI: 10.1016/j.jchf.2020.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Alqahtani MS, Abbas M, Alsabaani A, Alqarni A, Almohiy HM, Alsawqaee E, Alshahrani R, Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect Drug Resist 2022;15:1175-89. [PMID: 35345472 DOI: 10.2147/IDR.S351318] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wand AL, Russell SD, Gilotra NA; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions. Heart International 2021;15:49. [DOI: 10.17925/hi.2021.15.1.49] [Reference Citation Analysis]
12 Liang LW, Kalia I, Latif F, Waase MP, Shimada YJ, Sayer G, Reilly MP, Uriel N. The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic. Mol Genet Genomic Med 2022;10:e1946. [PMID: 35388985 DOI: 10.1002/mgg3.1946] [Reference Citation Analysis]
13 Rassaf T, Totzeck M, Mahabadi AA, Hendgen-Cotta U, Korste S, Settelmeier S, Luedike P, Dittmer U, Herbstreit F, Brenner T, Klingel K, Hasenberg M, Walkenfort B, Gunzer M, Schlosser T, Weymann A, Kamler M, Schmack B, Ruhparwar A. Ventricular assist device for a coronavirus disease 2019-affected heart. ESC Heart Fail. 2021;8:162-166. [PMID: 33219613 DOI: 10.1002/ehf2.13120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Manemann SM, Gerber Y, Bielinski SJ, Chamberlain AM, Margolis KL, Weston SA, Killian JM, Roger VL. Recent trends in cardiovascular disease deaths: a state specific perspective. BMC Public Health 2021;21:1031. [PMID: 34074276 DOI: 10.1186/s12889-021-11072-5] [Reference Citation Analysis]
15 Reid KRY. Why Automated E-Counseling for Chronic Heart Failure Matters in the COVID-19 Pandemic Era. Circ Heart Fail 2021;14:e008071. [PMID: 33464946 DOI: 10.1161/CIRCHEARTFAILURE.120.008071] [Reference Citation Analysis]
16 Siniorakis E, Arvanitakis S, Katsianis A, Nikolopoulos I. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. J Korean Med Sci 2021;36:e113. [PMID: 33876590 DOI: 10.3346/jkms.2021.36.e113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Butler J, Anker SD, Siddiqi TJ, Coats AJS, Dorigotti F, Filippatos G, Friede T, Göhring UM, Kosiborod MN, Lund LH, Metra M, Moreno Quinn C, Piña IL, Pinto FJ, Rossignol P, Szecsödy P, Van Der Meer P, Weir M, Pitt B. Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. Eur J Heart Fail 2021. [PMID: 34800079 DOI: 10.1002/ejhf.2386] [Reference Citation Analysis]
18 IsHak WW, Korouri S, Darwish T, Vanle B, Dang J, Edwards G, Black JT, Aronow H, Kimchi A, Spiegel B, Hedrick R, Chernoff R, Diniz MA, Mirocha J, Manoukian V, Harold J, Ong MK, Wells K, Hamilton M, Danovitch I. Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial. PLoS One 2021;16:e0244453. [PMID: 33412562 DOI: 10.1371/journal.pone.0244453] [Reference Citation Analysis]
19 Zakrzewski J, Coyle L, Aicher T, Chickerillo K, Gallagher C, Kuper K, Sciamanna C, Chau VQ, Tatooles A. Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device. ASAIO J 2021;67:1189-95. [PMID: 34475334 DOI: 10.1097/MAT.0000000000001578] [Reference Citation Analysis]
20 Aleksova A, Sinagra G, Beltrami AP, Pierri A, Ferro F, Janjusevic M, Gagno G. Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era. ESC Heart Fail 2021. [PMID: 34609075 DOI: 10.1002/ehf2.13595] [Reference Citation Analysis]
21 Yuan N, Botting PG, Elad Y, Miller SJ, Cheng S, Ebinger JE, Kittleson MM. Practice Patterns and Patient Outcomes After Widespread Adoption of Remote Heart Failure Care. Circ Heart Fail 2021;14:e008573. [PMID: 34587763 DOI: 10.1161/CIRCHEARTFAILURE.121.008573] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ferreira VV, Pereira-da-Silva T, Cacela D, Ferreira RC. [Remote invasive monitoring of pulmonary artery pressures in heart failure patients: Initial experience in Portugal in the context of the Covid-19 pandemic]. Rev Port Cardiol 2021. [PMID: 34840416 DOI: 10.1016/j.repc.2021.06.016] [Reference Citation Analysis]
23 Bayes-Genis A, Codina P, Abdul-Jawad Altisent O, Santiago E, Domingo M, Cediel G, Spitaleri G, Lupón J. Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal. Eur Heart J Suppl 2020;22:P29-32. [PMID: 33390867 DOI: 10.1093/eurheartj/suaa169] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 DeFilippis EM, Psotka MA, Ibrahim NE. Promoting Health Equity in Heart Failure Amid a Pandemic. JACC Heart Fail 2021;9:74-6. [PMID: 33384065 DOI: 10.1016/j.jchf.2020.11.002] [Reference Citation Analysis]
25 Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Hoster C, Lavani P, Nair GG, Jahan N, Alan Simmons J, Rao AK, Cotts W, Williams K, Volgman AS, Marinescu K, Suboc T. Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. Am Heart J Plus 2021;4:100022. [PMID: 34151308 DOI: 10.1016/j.ahjo.2021.100022] [Reference Citation Analysis]
26 Rao VN, Kelsey MD, Kelsey AM, Russell SD, Mentz RJ, Patel MR, Fudim M. Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic. Clin Cardiol 2021;44:656-64. [PMID: 33682157 DOI: 10.1002/clc.23590] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Hill L, Lambrinou E, Moser DK, Beattie JM. The COVID-19 pandemic: challenges in providing supportive care to those with cardiovascular disease in a time of plague. Curr Opin Support Palliat Care 2021;15:147-53. [PMID: 33843761 DOI: 10.1097/SPC.0000000000000552] [Reference Citation Analysis]
28 Marcondes-Braga FG, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Simões MV, Fernandes-Silva MM, Rassi S, Alves SMM, Albuquerque DC, Almeida DR, Bocchi EA, Ramires FJA, Bacal F, Rossi Neto JM, Danzmann LC, Montera MW, Oliveira Junior MT, Clausell N, Silvestre OM, Bestetti RB, Bernadez-Pereira S, Freitas AF Jr, Biolo A, Barretto ACP, Jorge AJL, Biselli B, Montenegro CEL, Santos Júnior EGD, Figueiredo EL, Fernandes F, Silveira FS, Atik FA, Brito FS, Souza GEC, Ribeiro GCA, Villacorta H, Souza Neto JD, Goldraich LA, Beck-da-Silva L, Canesin MF, Bittencourt MI, Bonatto MG, Moreira MDCV, Avila MS, Coelho Filho OR, Schwartzmann PV, Mourilhe-Rocha R, Mangini S, Ferreira SMA, Figueiredo Neto JA, Mesquita ET. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021. Arq Bras Cardiol 2021;116:1174-212. [PMID: 34133608 DOI: 10.36660/abc.20210367] [Reference Citation Analysis]
29 Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, Correa A, Defilippis EM, Joyce E, Sauer AJ, Solomon SD, Vardeny O, Yancy C, Lala A. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail 2021:S1071-9164(21)00354-7. [PMID: 34481067 DOI: 10.1016/j.cardfail.2021.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Eckner D, Hofmann EM, Ademaj F, Martinovic K, Vogt F, Becher PM, Schrage B, Westermann D, Pauschinger M. Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume Centers. J Cardiovasc Dev Dis 2021;8:145. [PMID: 34821698 DOI: 10.3390/jcdd8110145] [Reference Citation Analysis]
31 Nan J, Jia R, Meng S, Jin Y, Chen W, Hu H. The Impact of the COVID-19 Pandemic and the Importance of Telemedicine in Managing Acute ST Segment Elevation Myocardial Infarction Patients: Preliminary Experience and Literature Review. J Med Syst 2021;45:9. [PMID: 33404890 DOI: 10.1007/s10916-020-01703-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
32 Murat B, Murat S, Mert KU, Bilgin M, Cavusoglu Y. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Acta Cardiol 2022;77:37-44. [PMID: 34218753 DOI: 10.1080/00015385.2021.1945765] [Reference Citation Analysis]
33 Cowie MR, Mourilhe-Rocha R, Chang HY, Volterrani M, Ban HN, de Albuquerque DC, Chung E, Fonseca C, Lopatin Y, Serrano JAM, Mircheva L, Moncada-Paz GA, Pagava Z, Reyes EB, Saldarriaga C, Schwartzmann P, Leng DSK, Trivi M, Yotov YT, Zieroth S; OPTIMIZE Heart Failure Care program coordinators. The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network. Int J Cardiol 2022:S0167-5273(22)00922-6. [PMID: 35750302 DOI: 10.1016/j.ijcard.2022.06.022] [Reference Citation Analysis]
34 Mihalj M, Mosbahi S, Schmidli J, Heinisch PP, Reineke D, Schoenhoff F, Kadner A, Schefold JC, Räber L, Potapov EV, Luedi MM. Providing safe perioperative care in cardiac surgery during the COVID-19 pandemic. Best Pract Res Clin Anaesthesiol 2021;35:321-32. [PMID: 34511222 DOI: 10.1016/j.bpa.2021.01.002] [Reference Citation Analysis]
35 Peng Q, Yang Q. Risk factors and management of pulmonary infection in elderly patients with heart failure: A retrospective analysis. Medicine (Baltimore) 2021;100:e27238. [PMID: 34559121 DOI: 10.1097/MD.0000000000027238] [Reference Citation Analysis]
36 Trenta AM, Belloni S, Ausili D, Caruso R, Arrigoni C, Russo S, Moro M, Vellone E, Dellafiore F. What is the lived experience of patients with left ventricular assist devices during the COVID-19 pandemic? A qualitative analysis. Eur J Cardiovasc Nurs 2021:zvab097. [PMID: 34741597 DOI: 10.1093/eurjcn/zvab097] [Reference Citation Analysis]
37 Popiolek-Kalisz J, Kalisz G. Cardiac Resynchronization Therapy Remote Monitoring - COVID-19 Pandemic Experiences and Future Perspectives. Curr Probl Cardiol 2021;:100874. [PMID: 33994038 DOI: 10.1016/j.cpcardiol.2021.100874] [Reference Citation Analysis]
38 Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, Pedrazzini G, Dauw J, Ameri P, Vicenzi M. Telemedicine in Heart Failure During COVID-19: A Step Into the Future. Front Cardiovasc Med 2020;7:612818. [PMID: 33363223 DOI: 10.3389/fcvm.2020.612818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
39 Battineni G, Sagaro GG, Chintalapudi N, Amenta F. The Benefits of Telemedicine in Personalized Prevention of Cardiovascular Diseases (CVD): A Systematic Review. J Pers Med 2021;11:658. [PMID: 34357125 DOI: 10.3390/jpm11070658] [Reference Citation Analysis]
40 Wagner JR, Ambrosy AP. Hospitalizations for heart failure and mortality risk during the evolving coronavirus disease 2019 pandemic - the wave may break but a dangerous undertow persists. Eur J Heart Fail 2020;22:2225-7. [PMID: 33125819 DOI: 10.1002/ejhf.2043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. World J Cardiol 2021; 13(8): 298-308 [PMID: 34589166 DOI: 10.4330/wjc.v13.i8.298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Nan J, Zhang T, Tian Y, Song K, Li Q, Fu Q, Ma Y, Jin Z. Impact of the 2019 Novel Coronavirus Disease Pandemic on the Performance of a Cardiovascular Department in a Non-epidemic Center in Beijing, China. Front Cardiovasc Med 2021;8:630816. [PMID: 33681305 DOI: 10.3389/fcvm.2021.630816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Mariani S, Schöde A, Homann K, Feueriegel S, Nöth S, Warnke K, Bounader K, Andreeva A, Li T, Dogan G, Haverich A, Schmitto JD. Telemonitoring and Care Program for Left Ventricular Assist Device Patients During COVID-19 Outbreak: A European Experience. ASAIO J 2021;67:973-81. [PMID: 34403376 DOI: 10.1097/MAT.0000000000001526] [Reference Citation Analysis]
44 Chu C, Stamenova V, Fang J, Shakeri A, Tadrous M, Bhatia RS. Title: The association between telemedicine use and changes in healthcare utilization and outcomes in patients with congestive heart failure: a retrospective cohort study. JMIR Cardio 2022. [PMID: 35881831 DOI: 10.2196/36442] [Reference Citation Analysis]
45 Soeiro AM, Pêgo-Fernandes PM. Post-COVID-19 cardiological alterations. Sao Paulo Med J 2021;139:543-4. [PMID: 34468629 DOI: 10.1590/1516-3180.2021.139628062021] [Reference Citation Analysis]
46 Ijaz SH, Shah SP, Majithia A. Implantable devices for heart failure monitoring. Prog Cardiovasc Dis 2021:S0033-0620(21)00130-4. [PMID: 34838788 DOI: 10.1016/j.pcad.2021.11.011] [Reference Citation Analysis]
47 Birati EY, Najjar SS, Tedford RJ, Houston BA, Shore S, Vorovich E, Atluri P, Urgo K, Molina M, Chambers S, Escobar N, Hsich E, Estep JD, Alexander KM, Teuteberg JJ, Chaudhry SP, Ravichandran A, DeVore AD, Margulies KB, Hanff TC, Zimmer R, Kilic A, Wald JW, Vidula H, Martens J, Blumberg EA, Mazurek JA, Owens AT, Goldberg LR, Alvarez-Garcia J, Mancini DM, Moss N, Genuardi MV. Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. Circ Heart Fail 2021;14:e007957. [PMID: 33813838 DOI: 10.1161/CIRCHEARTFAILURE.120.007957] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bocchi EA, Lima IGCV, Biselli B, Salemi VMC, Ferreira SMA, Chizzola PR, Munhoz RT, Pessoa RS, Cardoso FAM, Bello MVO, Hajjar LA, Gomes BR. Worsening of heart failure by coronavirus disease 2019 is associated with high mortality. ESC Heart Fail 2021;8:943-52. [PMID: 33498096 DOI: 10.1002/ehf2.13199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]